ArticleCancer immunology, immunotherapy : CII2023

Integrative analyses of bulk and single-cell RNA-seq identified cancer-associated fibroblasts-related signature as a prognostic factor for immunotherapy in NSCLC.

Shasha Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.